Opportunistic Salpingectomy at the Time of Benign Laparoscopic Hysterectomy (SLH)
Status
Conditions
Treatments
Details and patient eligibility
About
In this prospective study, patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy were included. The aim of this study is to assess the prevalence of tubal histopathological abnormalities such as Serous Tubal Intraepithelial Carcinoma (STIC) and tumor protein 53 (p53) signatures) as well as the prevalence of perioperative and postoperative complications related to opportunistic laparoscopic salpingectomy in a low risk population. The hypothesis is that prophylactic salpingectomy during benign laparoscopic hysterectomy is both feasible and innocuous. Peri- and postoperative complications, duration of salpingectomy and post-salpingectomy blood loss, histopathological and immunohistochemical analysis with anti-p53 antibody were evaluated.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- patients who underwent benign laparoscopic hysterectomy with systematic salpingectomy
Exclusion criteria
- Hysterectomy in a context of gynecologic cancer
- Hysterectomy not carried out using laparoscopy
- Fimbriated end missing or damaged or impossible for pathologist to analyze
Trial design
100 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal